Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Franceschini

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
The Journal of Rheumatology|October 3, 2015
Dr. Reggia, et al, replyRossella Reggia, Angela Tincani, Franco Franceschini, et al.
The Lancet. Rheumatology|August 25, 2020
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control studyMicaela Fredi, Ilaria Cavazzana, Liala Moschetti, et al.
Current Rheumatology Reports|March 16, 2018
Update on Antiphospholipid Syndrome: Ten Topics in 2017Ilaria Cavazzana, Laura Andreoli, Maarteen Limper, et al.
Clinical and Experimental Rheumatology|September 9, 2014
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitisIlaria Cavazzana, Mara Taraborelli, Micaela Fredi, et al.
Clinical Reviews in Allergy & Immunology|October 31, 2015
The Clinical and Histological Spectrum of Idiopathic Inflammatory MyopathiesIlaria Cavazzana, Micaela Fredi, Carlo Selmi, et al.
Clinical and Experimental Rheumatology|February 10, 2023
Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control studyLiala Moschetti, Maria Grazia Lazzaroni, Ilaria Cavazzana, et al.
Clinical and Experimental Rheumatology|November 7, 2023
Long-term organ damage accrual and late mortality in systemic sclerosisMaria Grazia Lazzaroni, Liala Moschetti, Marta Breda, et al.
Clinical and Experimental Rheumatology|August 6, 2013
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodiesIlaria Cavazzana, Micaela Fredi, Mara Taraborelli, et al.
Autoimmunity|May 28, 2013
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosusStefania Cartella, Ilaria Cavazzana, Angela Ceribelli, et al.
Clinical and Experimental Rheumatology|March 9, 2021
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et alSilvia Piantoni, Chiara Bazzani, Emirena Garrafa, et al.
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
The Journal of Rheumatology|October 3, 2015
Dr. Reggia, et al, replyRossella Reggia, Angela Tincani, Franco Franceschini, et al.
The Lancet. Rheumatology|August 25, 2020
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control studyMicaela Fredi, Ilaria Cavazzana, Liala Moschetti, et al.
Current Rheumatology Reports|March 16, 2018
Update on Antiphospholipid Syndrome: Ten Topics in 2017Ilaria Cavazzana, Laura Andreoli, Maarteen Limper, et al.
Clinical and Experimental Rheumatology|September 9, 2014
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitisIlaria Cavazzana, Mara Taraborelli, Micaela Fredi, et al.
Clinical Reviews in Allergy & Immunology|October 31, 2015
The Clinical and Histological Spectrum of Idiopathic Inflammatory MyopathiesIlaria Cavazzana, Micaela Fredi, Carlo Selmi, et al.
Clinical and Experimental Rheumatology|February 10, 2023
Anti-Th/To antibodies in systemic sclerosis: analysis of long-term follow-up of pulmonary involvement, organ damage accrual and mortality in an Italian cohort with a case-control studyLiala Moschetti, Maria Grazia Lazzaroni, Ilaria Cavazzana, et al.
Clinical and Experimental Rheumatology|November 7, 2023
Long-term organ damage accrual and late mortality in systemic sclerosisMaria Grazia Lazzaroni, Liala Moschetti, Marta Breda, et al.
Clinical and Experimental Rheumatology|August 6, 2013
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodiesIlaria Cavazzana, Micaela Fredi, Mara Taraborelli, et al.
Autoimmunity|May 28, 2013
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosusStefania Cartella, Ilaria Cavazzana, Angela Ceribelli, et al.
Clinical and Experimental Rheumatology|March 9, 2021
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et alSilvia Piantoni, Chiara Bazzani, Emirena Garrafa, et al.
Pageof 24